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Abstract
Pericytes surround capillary endothelial cells and exert contractile forces modulating microvascular
tone and endothelial growth. We previously described pericyte contractile phenotype to be Rho
GTPase- and α–smooth muscle actin (αSMA)-dependent. However, mechanisms mediating
adhesion-dependent shape changes and contractile force transduction remain largely equivocal. We
now report that the neutral cysteine protease, calpain, modulates pericyte contractility and cellular
stiffness via talin, an integrin-binding and F-actin associating protein. Digital imaging and
quantitative analyses of living cells reveal significant perturbations in contractile force transduction
detected via deformation of silicone substrata, as well as perturbations of mechanical stiffness in
cellular contractile subdomains quantified via atomic force microscope (AFM)-enabled
nanoindentation. Pericytes overexpressing GFP-tagged talin show significantly enhanced
contractility (~two-fold), which is mitigated when either the calpain-cleavage resistant mutant talin
L432G or vinculin are expressed. Moreover, the cell-penetrating, calpain specific inhibitor termed
CALPASTAT reverses talin-enhanced, but not Rho GTP-dependent, contractility. Interestingly, our
analysis revealed that CALPASTAT, but not its inactive mutant, alters contractile cell-driven
substrata deformations while increasing mechanical stiffness of subcellular contractile regions of
these pericytes. Altogether, our results reveal that calpain-dependent cleavage of talin modulates cell
contractile dynamics, which in pericytes may prove instrumental in controlling normal capillary
function or microvascular pathophysiology.
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Introduction
Regulation of microvascular remodeling during physiologic and pathologic angiogenesis
involves multiple, dynamic interactions between endothelial cells (EC) and pericytes (Jain
2003;Folkman 1971;Kutcher and Herman 2009). Pericytes surround the capillary endothelium,
communicating directly through the basement membrane via gap junctions or soluble factors:
these interactions modulate microvascular stability, angiogenesis, capillary contractility and
blood flow (Kutcher and Herman 2009;Darland and D'Amore 1999;Rucker et al 2000). Indeed,
pericyte-EC associations have been demonstrated to regulate vascular maturation (Darland and
D'Amore 2001a), and it has been conclusively established that soluble mediators and pericyte
contacts control EC growth and survival via TGF-beta and VEGF (Darland and D'Amore
2001b;Darland et al 2003;Shih et al 2003;Sieczkiewicz and Herman 2003;Papetti et al 2003).
Reciprocally, ECs are postulated to recruit and maintain differentiated pericytes in the
microvascular niche via growth factors including FGF-2 (Healy and Herman 1992) and PDGF
(Bjarnegard et al 2004;Wilkinson-Berka et al 2004). Such pericyte-EC interactions modulate
EC proliferation (Orlidge and D'Amore 1987) and migration (Sato and Rifkin 1989), prevent
microvascular regression (Benjamin, Hemo and Keshet 1998), and can stabilize nascent
microvessels during development (von Tell, Armulik and Betsholtz 2006). Finally, we have
recently demonstrated that pericyte contraction is sufficient to modulate the mechanical niche
of adjacent EC, either via direct contractile strain or indirect modulation of the mechanical
stiffness of strained basement membrane (Lee et al 2010). Thus, it is becoming increasingly
apparent that pericytes play key regulatory roles in modulating microvascular remodeling,
capillary contractility and blood flow.
Pericyte control of microvascular remodeling and capillary tonus has been implicated as
dependent on Rho GTP, Rho kinase, and isoactin (Kutcher and Herman 2009;Kolyada, Riley
and Herman 2003;Kutcher et al 2007). Indeed, previous studies have revealed that signaling
through pericyte Rho GTP enhances pericyte contractility specifically through the α–smooth
muscle actin (αSMA) cytoskeletal network. Furthermore, pericyte control of EC proliferation
is similarly sensitive to pericyte-dependent contractility, since modulating pericyte Rho GTP
reversibly regulates endothelial growth regardless of whether pericytes and EC are in direct
cell contact (Kutcher et al 2007). In this way, pericyte mechanotransduction may prove
instrumental in modulating EC growth during pathologic angiogenesis that would not depend
on “pericyte dropout” or death as the initiating signal/event (Kutcher and Herman
2009;Kutcher et al 2007).
If mechanical force transduction plays an instrumental role in regulating endothelial dynamics
during physiologic or pathologic angiogenesis, then one might posit that the key interface of
interest is the cell membrane, which links the cytoskeleton to the extracellular matrix or
adjacent cells through specific adhesive ligand-receptor complexes. Indeed, macromolecular
focal adhesion complexes or FAs coordinate such dynamic interactions and participate in force
transduction. Transmembrane integrins are key FA components that act as adhesion receptors
via binding to extracellular matrix (ECM) ligands (Hynes 2002;Berrier and Yamada 2007).
These integrins cluster in a calpain-dependent manner (Bialkowska et al 2000); the active
remodeling of these FA-cytoskeletal protein assemblies occurs by recruiting cytoskeletal actin
adaptors and regulators via β–integrin cytoplasmic tails. Key adaptor proteins include vinculin,
α-actinin, paxillin, zyxin and talin (Zamir and Geiger 2001;Zaidel-Bar et al 2007). Among
these FA components, talin 1 not only binds and activates integrins (Banno and Ginsberg
2008;Wegener et al 2007; Moes et al 2007), but also binds to F-actin (Gingras et al 2008),
providing a direct link between the ECM and cytoskeleton. Talin 1 increasingly binds to
vinculin under applied mechanical strain, and signals cytoskeletal remodeling (Izard and
Vonrhein 2004;del Rio et al 2009). Consequently, talin 1 is considered a key player in FA
mechanosensory function, coordinating cell adhesion and supporting mechanotransduction
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while reinforcing integrin-cytoskeletal interactions (del Rio et al 2009;Arnaout, Goodman and
Xiong 2007;Roberts and Critchley 2009;Roca-Cusachs et al 2009).
Previous studies have suggested that FA remodeling, including talin’s role in coordinating
membrane-cytoskeleton interactions, is regulated by the calcium-dependent protease, calpain
(Franco et al 2004;Franco and Huttenlocher 2005). This family of proteases is broadly
implicated in cellular processes such as proliferation, differentiation, apoptosis, adhesion,
spreading, migration and angiogenesis (Croall and Ersfeld 2007;Goll et al 2003;Ma et al
2009), as well as in pathologies such as retinal degeneration (Paquet-Durand, Johnson and
Ekstrom 2007;Azuma and Shearer 2008) and cancer cell invasion (Cortesio et al 2008).
Activity of two major isoforms, calpain 1 and calpain 2, is tightly regulated in a spatially and
temporally specific fashion by phosphorylation, calcium binding-requirement, and by a
specific cellular inhibitor, calpastatin (Franco and Huttenlocher 2005;Hanna, Campbell and
Davies 2008). Indeed, others have demonstrated the key roles that calpains play in modulating
cytoskeletal dynamics during cell spreading and migration (Shuster and Herman
1995;Huttenlocher et al 1997;Croce et al 1999;Potter et al 1998). In addition, calpain is required
for the formation of nascent integrin clusters, which evolve into active Rac-containing focal
complexes and into active RhoA-containing FAs (Kulkarni et al 1999). More recently, it has
been shown that the FA dynamics are regulated by calpain cleavage of talin, since expression
of the calpain-resistant talin mutant L432G perturbs FA protein turnover (Franco et al 2004).
Considering the pivotal role of pericytes in modulating microvascular morphogenesis in
vivo, the connection between pericyte contraction and EC proliferation in vitro, and finally the
regulation of FA dynamics by calpain, we have become interested in exploring the mechanisms
that calpain may play in pericyte contractile force and, in turn, capillary contractility. Here, we
report a series of experiments designed to test directly whether talin and calpain have the ability
to regulate pericyte contractility. Using purified populations of bovine retinal pericytes and a
deformable silicone substratum contractility assay, we compared the contractile phenotype of
pericytes overexpressing GFP-tagged talin with those bearing a talin L432G mutant that is
resistant to calpain cleavage. In related experiments, we quantified the influence of
overexpressed vinculin and constitutively activated RhoA Q63L on pericyte contractility.
Finally, to explore the molecular mechanisms controlling pericyte contractility in response to
talin and RhoGTP-dependent signaling, we conducted atomic force microscopy (AFM)-
enabled nanoindentation to quantify the subcellular stiffness of pericytes in situ, in the presence
of a cell-penetrating calpain-specific inhibitor developed in our laboratory, termed
CALPASTAT, and its inactive point mutant (Croce et al 1999). Together, these experiments
demonstrate that calpain-mediated signaling, in concert with talin, is a critical component of
interactions at the pericyte cytoskeleton-membrane interface that regulate cell contractility and
local cell stiffness. In turn, these observations may lend important insights into the manner in
which chemomechanical force transduction and cytoskeletal-membrane signaling networks
coordinate microvascular phenomena during development or disease.
Materials and Methods
Cell Culture
Primary cultures of bovine retinal pericytes (BRP) were isolated and characterized as described
previously (Herman and D'Amore 1985). Vascular smooth muscle actin (SMA)-, NG2
proteoglycan- and 3G5-positive and CD-31- and di-I-acyl-LDL-negative pericyte cultures
were grown in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with penicillin,
streptomycin, Fungizone (all from Invitrogen, Carlsbad, CA) and 10% calf serum (CS, from
Atlanta Biologicals. Lawrenceville, GA), and used for experiments between passage 2 and 4.
Pericytes were grown in tissue culture plasticware (Corning, Inc., Corning, NY): T175 flasks
(for expansion prior to experiments) and vessels of 24-well plate or 8-chamber slide format
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(for experiments proper), in a total volume of 1 ml per well or 0.5 ml per chamber, while
incubated at 37°C in 5% CO2 atmosphere.
Plasmids
The following plasmids were used: pEGFP-C1 empty vector (Clontech Inc., USA) expressing
enhanced green fluorescent protein, EGFP-C1 fusion with mouse talin 1 and talin 1 mutant
L432G (courtesy of Dr. A. Huttenlocher, University of Wisconsin-Madison), EGFP-C1 fusion
with vinculin (courtesy of Dr. Susan Craig, Johns Hopkins University), pExv and pExv/RhoA
(Q63L) expressing dominant active form of RhoA (RhoDA) (courtesy of Dr. Deniz Toksoz,
Tufts University). Plasmid DNAs were prepared with endotoxin-free maxi kits (Qiagen).
Electroporation
One day before electroporation, pericytes were seeded at the density of 0.5 – 0.7 × 106 pericytes
per T175, to obtain ca. 60–70 % confluency on the next day. The electroporation mixture was
prepared a 1.5 ml tube by including (per sample) 18 µl of supplement and 82 µl of solution
(both from Basic Nucleofactor Kit for Primary Endothelial Cells, Lonza, Cat. No. VpI-1001),
15 µg of plasmids expressing EGFP fusion constructs or 12 µg of RhoA Q63L plasmid mixed
with 3 µg of pEGFP-C1 plasmid (4:1 ratio). This mixture (110–120 µl) was added to 0.5 – 1
× 106 pericytes, which were freshly harvested (trypsinized, counted in hemacytometer, washed
and spun in 10 ml of growing medium in 15 ml conical tubes, in a bench top Sorvall RT6000B
centrifuge at 700 rpm, 10 min at room temperature). Cells gently re-suspended in
electroporation mixture were transferred to individual 4 mm electroporation cuvettes and
electroporated using Harvard Apparatus BTX electroporator set for 2 pulses of 5 milliseconds
each at 200 V, with an interval of 1 second. Five minutes after electroporation, 0.5 ml of
growing medium was added to each cuvette with electroporated cells, and the whole volume
was transferred to 15 ml tube, raised with growing medium to an appropriate volume and
dispensed into duplicate experimental culture vessels. Using these constructs, electroporation-
optimized transfection efficiently yields up to 45% GFP-positive cellular transfectants as
ascertained by flow cytometry vs. 2–10% transfectants typically achieved using standard
cationic lipid-based transfection reagents. Only electorporation was used as a method to obtain
data from experiments involving overexpression of proteins in the bovine primary pericytes in
this study.
Analysis of Pericyte Contractile Phenotype
Preparation of Deformable Silicone Substrates—Deformable silicone substrata for
analysis of pericyte contractility in cultures were prepared as described previously (Harris et
al, 1980;Kutcher et al., 2007) with the following modifications. Eight µl of silicone
(dimethylpolysiloxane, Sigma cat. # DMPS12M-100G) was pipetted with a positive
displacement pipette to spread for 1 hr at 42°C onto round 12 mm glass coverslips or chambers
of 8-chamber glass culture slide, from which plastic dividers were removed. Silicone on glass
coverslips or slides was thermally crosslinked by passing through a Bunsen burner flame. A
glow plasma discharge apparatus (Aebi and Pollard, 1987) was used to generate a plasma
discharge onto silicone-coated coverslips or chamber slides (1 min vacuum pump, followed
by 1 min discharge). After re-assembling plastic dividers onto glass culture slides or placing
coverslips into wells of a 24-well plate, the charged silicone surface was coated with 100 µl
of 0.1 mg/ml Type I collagen (BD Biosciences) in PBS and UV irradiated for 3 min in a sterile
hood, enabling subsequent cell attachment in the transiently hydrophilic environment.
Approximately 2 – 4 × 103 cells in 0.5 ml of growing medium were seeded onto prepared
silicone coated coverslips or chamber slides and cultured for 24 hours prior to experiments
unless otherwise noted.
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Quantification of Contractile Force Production in Pericytes—On the next day after
seeding, silicone-attached pericytes within 8-chamber culture slides or 24-well plates were
examined via optical microscopy. Samples were mounted onto the motorized Ludl stage of a
Zeiss Axiovert 200M computer-assisted light microscope imaging workstation within a 37°C
stabilized, temperature-controlled environment, to enable live cell viewing for protracted
periods of time. Corresponding phase-contrast and fluorescent microscopic images were
acquired and overlaid for morphometric analysis using Metamorph software (Universal
Imaging Corp.). Pericyte deformation of silicone substratum was scored as a manifestation of
the cell contractile phenotype. In order to quantify the contractile phenotype of the cells, we
defined an original parameter, designated as Cell Contractility Index (CCI), which describes
the extent of contraction in terms of number and length of substrata wrinkles per cell. We define
CCI as the normalized wrinkle index (WIexperimental sample/WIcontrol). We define this wrinkle
index as a weighted average of long and short wrinkles per actively contracting cell: WI =
(WL + 0.5 x WS) / n, where WL is the number of long wrinkles (spanning more than half of the
cell width at the wrinkle location), WS is the number of short wrinkles (spanning less than half
the cell width), and n is the number of actively contracting cells analyzed in a given culture
condition. Actively contracting cells were those cells that visibly wrinkled the silicone substrata
at the instance of WI measurement (24 hrs unless otherwise stated). Note that short wrinkles
were generally observed less frequently than long ones, and we corrected for the apparently
lower magnitude of contractile force at short wrinkles by halving this contribution to WI. In
experiments with transfected EGFP plasmids, CCI was analyzed in contracting cells expressing
EGFP fusion proteins. The normalized wrinkle index, CCI, was scored from at least 25
contracting cells in each experimental condition, and CCI of the control sample was set equal
to 1 in all stated results. Data from at least three independent experiments were graphed and
analyzed for p value of statistical significance (t-test of two-samples assuming unequal
variances). In the text and the figures, CCI values are presented as the average ± standard error
of measurement. The difference between two CCI data sets was considered statistically
significant when p<0.05.
Calpain inhibitors
Calpastat (abbreviated CALPST) is a synthetic 40 amino acid peptide previously developed in
our laboratories and described to be a specific, cell-penetrating inhibitor of calpain activity and
calpain-dependent in vivo cleavage of target proteins, including talin (Croce et al 1999; Potter
et al 2003). This peptide was synthesized and purified at Tufts University Core Facility,
reconstituted to a 25 mM stock in 0.1 M HEPES, pH 7.4, and used at final concentrations of
5, 25 or 100 µM to treat pericyte cultures. The alanine-substituted mutant of CALPST, termed
CALPST-ala, was also described above (Croce et al 1999) as an inactive control; this mutant
was synthesized, prepared and used in the same fashion as CALPST.
Measurement of local elastic moduli with atomic force microscopy
An atomic force microscope (AFM; PicoPlus, Agilent Technology) was incorporated within
an inverted optical microscope (IX81, Olympus) to enable facile positioning of AFM
cantilevered probes above pericyte apical surfaces (See Fig. 4). All mechanical characterization
experiments were conducted on living pericytes in full media at room temperature. Calibration
of AFM cantilevers of nominal spring constant k = 0.01 nN/nm and nominal probe radius R =
25 nm (MLCT-AUHW, Veeco) was conducted as described previously (Thompson et al 2006).
Briefly, inverse optical lever sensitivity [nm/V] (InvOLS) was measured from deflection-
displacement curves recorded on rigid glass substrates. Spring constants [nN/nm] of AFM
cantilevers were measured via thermal activation recording of deflection, and the Fast Fourier
Transform of cantilever free-end amplitude as a function of oscillation frequency was fitted as
a harmonic oscillator to obtain this value. For each measurement of effective elastic moduli at
any given location on any given cell, at least 30 replicate indentations were acquired to
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maximum depths of 10 nm. At least five cells were analyzed for each condition, and multiple
indentation locations (i.e., wrinkle positions) were associated with each cell, as indicated in
figure captions. Acquired probe deflection-displacement responses were converted offline
(Scanning Probe Imaging Processor, Image Metrology), using measured spring constants and
InvOLS, to force-depth responses. Effective elastic moduli Eeff were calculated by applying a
modified Hertzian model of spherical contact to the loading segment of the force-depth
response, as detailed elsewhere (Lee et al 2010;Thompson et al 2005) with the scientific
computing software Igor Pro (Wavemetrics). These Eeff values represent the local stiffnesses
of the subcellular domains probed in each experiment under contact loading, and are not
intended to indicate the elastic properties of the entire cell or the Young’s elastic modulus under
uniaxial loading. In Fig. 4, local cell stiffness values are normalized by Eeff measured in
untreated cells at subcellular domains located just above positions of substrata wrinkles. We
have shown through previous AFM and fluorescence imaging that these locations correspond
to regions of cell contraction that comprise F-actin stress fibers (Lee et al 2010). Hereafter,
subcellular domains corresponding to locations above wrinkles are denoted as “wrinkled
domain” and subcellular domains corresponding to locations far from substrata wrinkles as
“unwrinkled domain”. This terminology is intended to contrast the local cell stiffness at sites
of sustained contraction to that at sites remote from such visible contraction, within the same
cell. As in the wrinkling index observations described above, only actively contracting cells
(i.e., those producing substrata wrinkles) were analyzed.
Before elastic moduli measurement via AFM-enabled nanoindentation, x- and y-axes
hystereses of the closed loop piezoscanner were calibrated to improve the positioning of AFM
cantilevered probes on pericyte membranes and silicone substrata. The force that AFM
cantilevers exerted on pericyte membranes during contact mode imaging did not exceed 500
pN, which was chosen to minimize the effect of mechanical contact between pericytes and
AFM cantilevers during imaging that preceded mechanical characterization of subcellular
domains.
Computed elastic moduli Eeff are reported as average ± standard error of measurement. All
statistical analyses were conducted with one-way ANOVA (Tukey analysis), with statistical
significance in stiffness differences considered at p<0.05.
Results
Talin enhances pericyte contractility in calpain-dependent fashion
Previous work demonstrated a role for Rho GTP-dependent signaling in regulating pericyte
and isoactin-dependent contraction in vitro (Kolyada, Riley and Herman 2003;Kutcher et al
2007). In an effort to identify the upstream and downstream modulators that control contractile
phenotype, we now focus on that the roles of key focal adhesion and cytoskeletal associated
proteins in orchestrating pericyte contractile force exertion against adherent substrata. Since
talin is a key FA component that binds integrin and F-actin, and because these integrin-
cytoskeletal associations have been demonstrated to be calpain-sensitive (Franco et al 2004),
we were eager to learn whether overexpressing talin and vinculin or perturbing calpain-
mediated signaling might influence cellular contractility or stiffness. To directly assess the FA-
mediated and calpain-dependent regulation of force production in retinal pericytes, we utilized
a single cell-based contractility assay of cells grown to subconfluence on a thin sheet of
deformable silicone substrata (see Materials and Methods). In particular, we analyzed
contractility of retinal pericytes (RP) overexpressing control enhanced green fluorescent
protein (EGFP), EGFP-talin, an EGFP-calpain-resistant mutant talin L432G, or EGFP-
vinculin. Similarly, we took advantage of a Rho GTP expression plasmid, namely a dominant
active mutant RhoA Q63L, co-expressed with control EGFP constructs.
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In order to quantify contractile force transduction exerted by individual pericytes, we analyzed
cell-derived deformation of the elastic substratum directly underlying each contractile cell.
Real-time, digital imaging affords the opportunity to assess cellular dynamics and contractility.
Reviewing static images derived from these living cell studies enables a quantitative analysis
of the Cell Contractility Index (CCI; see Materials and Methods). The CCI proposed here takes
into account not only the number but also the extent of substratum deformation events (i.e.,
local wrinkling of the substratum). Generally, we observed no preferential distribution of
substrata wrinkles in relation to distal tips of extending filopodia, lamellar membrane ruffles
or pseudopodial extensions engaging isotonically contracting cytoskeletal domains. With
processes that are actively extending forward we observe that substrate deformation is confined
to the well anchored regions, which are closer to the cell body (focal adhesion-rich domains).
The accuracy of quantifying contractility in terms of CCI can further be validated by positive
control experiments, wherein overexpression of dominant active RhoA Q63L demonstrated
enhanced retinal pericyte contractility (CCI = 1.44 ± 0.18, p<0.05, Fig. 1b) as compared to the
pericytes expressing vector alone. These findings are consistent with previous work describing
RhoA Q63L expression in pericytes (Kutcher et al 2007). Using CCI analysis of pericytes
expressing constructs of interest and plated upon deformable silicone substrates, we observe
that pEGFP-talin overexpression significantly enhances pericytes contractility (1.89 ± 0.12,
p<4 × 10−9), when compared to EGFP expressing control cells (Fig. 1B). The point mutant of
talin L432G, which has been demonstrated previously to be resistant to calpain cleavage
(Franco et al 2004), exhibits no statistically significant change in CCI (1.11 ± 0.12, p=0.44) as
compared to the control EGFP-expressing cells. Interestingly, we observed that overexpression
of EGFP-vinculin, another protein component of focal adhesions and a target of calpain
cleavage, does not cause any statistically significant change in pericyte contractility (0.95 ±
0.11, p=0.77, Fig. 1B) as compared to the control cells. These results indicate the important
role of talin, but not vinculin, in modulating calpain-dependent cellular force transduction.
Calpain controls talin-enhanced, but not active RhoA-dependent pericyte contractility
Given that wild-type talin enhances pericyte contractility, and the calpain-resistant talin mutant
L432G does not, we hypothesized that the CCI-enhancing effect of talin’s overexpression
would be reversible by calpain-specific pharmacologic inhibitors. To test this hypothesis, we
took advantage of our previously described calpastatin-derived and cell-penetrating synthetic
peptide, CALPASTAT (hereafter abbreviated as CALPST), which was reported to penetrate
cells in vivo and specifically inhibit calpain activity (Croce et al 1999). As a control, we used
a cell-penetrating alanine-substituted mutant of CALPST (CALPST-ala), which was also
previously described to be inactive in inhibiting calpain activity and unable to prevent cleavage
of calpain targets such as talin (Croce et al 1999). These calpain-specific inhibitors were added
to living cell cultures following RP plating onto deformable substrata. As can be observed from
Fig. 2, CALPST concentrations of 5 and 25 µM do not have a statistically significant effect on
CCI at 24, 48 or 96 hr. However, 100 µM CALPST inhibits CCI by 48 hr, down to 0.65 ± 0.06
of the untreated control (p <0.0004); note that 100 µM CALPST-ala control does not influence
CCI (p <0.01). By 96 hr of 100 µM CALPST treatment, CCI inhibition is ~50% of control
values (p<2 × 10−7), with 100 µM CALPST-ala having no influence (p<6 × 10−5). Thus, the
100 µM CALPST inhibitory CCI effects at both 48 and 96 hr are significantly different from
CCI for corresponding untreated and CALPST-ala treated controls, and also from CCI for 25
µM CALPST at both treatment durations (p <0.01 and p <0.0005, respectively). Finally, we
found that the inactive inhibitor CALPST-ala has no significant effect on CCI under any
conditions tested (Fig. 2). In summary, these results show that the cell-penetrating and calpain-
specific inhibitor, CALPST, exhibits dose- and time-dependent inhibitory effects on pericyte
contractility.
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We next turned to studies aimed at revealing the calpain-dependence of talin-enhanced
contractility. To this end, pericytes electroporated with pEGFP-talin, or pEGFP-talin L432G
were left untreated or treated with CALPST as described (see Materials and Methods). As
shown in Fig. 1b, when pericytes overexpressing EGFP-talin are treated with 25 µM CALPST
for 24 hr, there is a 36% reduction in talin-induced contractility (0.64 ± 0.1, p<2 × 10−6), as
compared to untreated control cells. However, Fig. 3 shows that CALPST treatment does not
alter pericyte CCI when cells are transfected with either control pEGFP vector (0.97 ± 0.12,
p=0.85) or pEGFP-talin L432G (0.91 ± 0.09, p=0.82). Thus, the CALPST-dependent reversal
of calpain-regulated contractility (in terms of CCI) corroborates data derived from our
overexpression studies that indicated pericyte contractility to be talin- and calpain-dependent
(Fig. 1). Collectively, these findings reflect the important role that calpain plays in shaping
talin-dependent contractility.
Considering that activated RhoA Q63L enhances pericyte contractile force production (Fig. 1)
and that RhoA has itself been reported to be a calpain substrate linked to cytoskeletal
remodeling (Kulkarni, Goll and Fox 2002), we then asked to what extent pericyte contractile
force transduction induced by RhoA Q63L would be calpain-dependent. To address this
question, we tested whether RhoA Q63L-induced contractility would be modulated when
calpain activity is inhibited by CALPST. To this end, pericytes were co-electroporated with a
transfection marker, pEGFP, and either pExv-RhoA Q63L or pExv control plasmid.
Importantly, while RhoA Q63L increases contractility (1.44 ± 0.18, p<0.05; Fig. 1B), pericyte
CCI remains unaffected when RhoA L63-overexpressing cells are treated with CALPST (1 vs.
0.97 ± 0.13, p=0.52; Fig. 3). These results demonstrate that, unlike talin-enhanced contractility,
RhoA-induced contractility is not calpain-sensitive.
Calpain controls contractile related stiffness measured by AFM nanoindentation
AFM-enabled nanoindentation allows for direct physical measurement of local elastic
properties of living pericytes (Lee et al., 2010), and thus enables correlations between cell
contraction-induced silicone wrinkling and local cellular stiffness parameters (Fig. 4B). We
measured effective elastic moduli (Eeff) of subcellular regions located just above wrinkled
domains of the deformable silicone substrata, corresponding to stress fiber-enriched subcellular
domains, (Fig. 4A) as well as subcellular regions that are devoid of stress fibers, which are
located above substrata that are not actively being deformed (i.e., divorced from wrinkled
substratum regions, Fig. 4C). Although these Eeff are not intended to represent the mechanical
stiffness of the entire cell, such experiments provide quantitative comparisons of the
mechanical differences in contractile vs. noncontractile regions of the pericyte. These
measurements evaluated regions of untreated cells, as well as cells treated with 100 µM
CALPST or its inactive mutant CALPST-ala for 24 hr. In untreated cells, Eeff measured on
unwrinkled domains is lower (0.8 ± 0.05, p<0.05) as compared to wrinkled domains, thus
correlating increased local cell stiffness with enhanced contractile strain. We have shown
previously that, as expected, these regions of increased subcellular stiffness at wrinkled
substrata are also regions of actin cytoskeletal bundles (Lee et al., 2010). Interestingly,
inhibition of calpain by CALPST causes a statistically significant increase in stiffness on
wrinkled domains (1.3 ± 0.07, p<0.001 or 1.31 ± 0.07, p<0.001), as compared to such regions
in untreated cells or in CALPST-ala treated cells, respectively (Fig. 4D). Thus, the difference
in Eeff between wrinkled and unwrinkled domains in CALPST-treated cells is markedly
enhanced (p<0.001) when compared to untreated cells (p<0.05). This effect of CALPST on
subcellular stiffness is calpain-specific, since this effect is not observed in CALPST-ala treated
cells. In addition, Eeff on unwrinkled domains is essentially unchanged in either CALSPT or
CALPST-ala treated cells, as compared to untreated controls (p=0.825, Fig. 4D). This result
indicates that inhibition of calpain activity leads to locally increased stiffness during cell
contraction, whereas elastic properties of non-contractile regions remain unchanged.
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Discussion
In this study, we demonstrate that calpain and talin play pivotal roles in modulating multiple
aspects of pericyte-generated strains and contractile force transduction. In particular, we show
that talin, but not its calpain-resistant mutant or its binding partner vinculin, contributes
markedly to the extent of pericyte contractililty. These results, together with our earlier
described calpain cleavage studies of endogenous talin (Croce et al., 1999) and of EGFP-talin
(Franco et al., 2004), point to the importance of calpain-mediated talin cleavage as a mechanism
for regulating cellular contractility. We also demonstrate that calpain control of talin-enhanced
contractility apparently operates upstream or in parallel to RhoA-regulated cytoskeletal
remodeling since calpain inhibition can reverse talin-induced but, not RhoA L63-regulated
pericyte contraction. Moreover, calpain’s control over pericyte contractility is apparent
whether using cell-penetrating calpain-specific inhibitors in single cell-based contractility
assays or using direct measurement of subcellular stiffness via AFM-enabled nanoindentation.
These findings significantly extend earlier studies aimed at understanding the Rho GTP- and
cytoskeletal-dependent mechanisms that control pericyte contractility (Herman and D’Amore,
1985; Kolyada, Riley and Herman 2003; Kutcher et al 2007; Kutcher and Herman, 2009; Lee
et al 2010).
Calpain and talin control pericyte contractility
Using CCI, we observed that EGFP-talin overexpression significantly enhances pericyte
contractility as compared to control cells overexpressing EGFP alone (Fig. 1). These
observations are consistent with the studies in which talin 1 has been shown to be necessary
for reinforcement of integrin-mediated adhesion, linkage to actin cytoskeleton, and support of
mechanotransduction in murine fibroblasts (Roca-Cusachs et al 2009;Zhang et al 2008). On
the contrary, we observed no change of contractility in pericytes overexpressing a point mutant
of talin, L432G (Fig. 1b). Indeed, endogenous talin and EGFP-talin have been demonstrated
to be cleaved by calpain (Croce et al 1999 and Franco et al 2004, respectively), whereas EGFP-
talin L432G mutant has been shown to be resistant to calpain cleavage and to inhibit focal
adhesion dynamics (Franco et al 2004). Importantly, we observe differential effects of wild-
type and mutant talin L432G overexpression on pericyte contractility. This cannot be attributed
to differential localization of talin and this mutant in focal adhesions, as previous studies have
confirmed comparable patterns of FA-specific localization for both wild-type and mutant talin
L432G (Franco et al., 2004). Additionally, talin and its L432G mutant exhibit comparable
ability to interact with FAK and focal adhesion-targeted type I phospatidylinositol phosphate
kinase (PIPK 66) as well as to activate integrin (Franco et al 2004). In this context, our results
are consistent with the calpain-dependent cleavage of talin as a critical step in controlling
pericyte contractility, perhaps via modulating FA dynamics. This hypothesis is supported by
the observable time- and dose-dependent CCI inhibitory effect of CALPST, but not of its
mutant CALPST-ala (Fig. 2). Observations of the time-dependent CALSPT inhibition on
pericyte contractility (Fig. 2) can be related to previous reports describing calpain as an
abundant and long-lived enzyme with half-life of approximately five days (Zhang, Lane and
Mellgren 1996). This may explain why low concentrations and early timepoints for CALPST
treatment regimens (e.g., 25 µM at 24 hr) are seemingly below an observable threshold for
inhibiting spontaneous pericyte contractility. Taken together, these data indicate that talin- and
calpain-mediated signaling modulates pericyte contractility.
Talin, but not vinculin, enhances pericyte contractility in calpain-dependent fashion
Having established a critical role for calpain-dependent talin cleavage during cell contraction,
we sought to determine whether vinculin would also play a role in contractile force
transduction. By comparing effects of overexpressed talin to overexpressed vinculin in the
deformable silicone substrata assay, we showed that vinculin overexpression does not alter
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pericyte contractility (Fig. 1b), whereas talin overexpression does increase contractility. This
finding is consistent with the report that calpain cleavage of talin is a rate-limiting step in
controlling vinculin disassembly from FAs (Franco et al 2004). In addition, despite the well-
documented presence of vinculin in all integrin-containing FA structures (Gilmore and
Burridge 1996;Craig and Chen 2003;Zimerman, Volberg and Geiger 2004;Chen et al 2005),
it is widely reported that organization of FAs at the membrane critically depends on integrin-
talin binding but not on vinculin (Moulder et al 1996;Xu, Baribault and Adamson 1998). Talin
has also been demonstrated to be the most strongly bound component in the FA protein network
(Lele et al 2008). Furthermore, although vinculin has been suggested to contribute to strength
of cell adhesion (Gallant, Michael and Garcia 2005) and to act as a target for calpain cleavage
(Goll et al 2003;Weber et al 2009), it has also been shown that mechanical stretching of talin
unmasks its vinculin binding sites (del Rio et al 2009). Thus, it is likely that vinculin recruitment
and activation in FAs (Chen, Choudhury and Craig 2006) depends strongly on presence and
conformation of talin. Indeed, the present results demonstrate the central role that talin, but not
vinculin, possesses in modulating pericyte contractility.
Calpain alters contractility by differential control of talin, but not of activated RhoA
The RhoA/Rho kinase pathway is critically involved in many aspects of cardiovascular
physiology and pathophysiology (Loirand, Guerin and Pacaud 2006; Pacaud, Sauzeau and
Loirand 2005). Furthermore, since RhoA has been reported to be a calpain substrate (Goll et
al 2003), it was important to consider possible roles of calpain in RhoA-induced effects on
pericyte contractility. Our previous work demonstrated that Rho GTP-dependent induction of
pericyte contraction occurs in a αSMA-specific, but not non-muscle isoactin-dependent
manner (Kolyada, Riley and Herman 2003;Kutcher et al 2007). These earlier findings are
consistent with our observations indicating that constitutively active RhoA Q63L enhances
contractility. Importantly, however, we now appreciate that RhoA-driven pericyte contractility
is not calpain-dependent, since contractility is not reversible by the calpain-specific inhibitor
CALPST (Fig. 3). Together, these data point to the possibility that active RhoA and calpain
signal through the cytoskeletal network to influence contractile force transduction via parallel
pathways. Indeed, the same constitutively active mutant of RhoA Q63L enhances bovine aortic
endothelial (BAE) cell spreading, FA assembly and stress fiber formation even in the presence
of the calpain inhibitor, calpeptin (Kulkarni et al 1999). Similarly, calpain-dependent
remodeling of FA components may influence adhesion-dependent and contractile mechanisms
in an isoactin-dependent manner. For example, endothelial cells express non-muscle (β,γ)
isoactins while pericytes express non-muscle (β,γ) and smooth muscle (α) contractile protein
isoforms (Kutcher and Herman 2009; Herman and D'Amore 1985). That pericyte and
endothelial RhoA signaling is seemingly calpainin-sensitive suggests that earlier, upstream
events modulate the calpain-, Rac- and RhoA-dependent signaling events that contribute to
altered cell shape and contractile phenotype observed by us and by others (Bialkowska et al
2000). This may also explain why we could not observe any increase in Rho-induced pericyte
contractility in cells treated with CALPST; and that CALPST treatment did not reduce active
RhoA-induced contractility, but could completely reverse talin-enhanced contractility as
quantified by CCI (Fig. 3). These data are consistent with a model which postulates that calpain
operates upstream of active RhoA, enabling talin cleavage to differentially control contractile
force transduction at mature focal adhesions.
Calpain modulates stiffness of pericyte contractile domains
Local effective stiffness of subcellular domains Eeff was quantified in contractile pericytes via
AFM-enabled indentation, both at cell locations just above the substrata wrinkles (“wrinkled
domains”) and at cell locations remote from those contractile zones (“unwrinkled domains”).
We found that Eeff of the stress fiber-enriched pericyte domains at substrata wrinkles was
greater than the subcellular stiffness far from such wrinkles (Fig. 4), as is consistent with the
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stress-fiber enrichment at the “wrinkled domains”. Importantly, Eeff markedly increased in
response to calpain inhibition by CALPST (Fig. 4). CALPST also decreased the number of
contractile substrata deformations per cell as quantified by CCI (Fig. 2), viz. local cell stiffness
at sites of substrata wrinkling was increased, but the ability of cells to deform their underlying
substrata was decreased in response to calpain inhibition.
The observed increase in stiffness of the subcellular contractile regions in response to calpain
inhibition can be explained readily by the regulatory role(s) that calpain-mediated remodeling
of focal adhesion-associated cytoskeletal proteins play in modifying these extracellular matrix-
interacting, cytoskeletal-plasma membrane contact zones. As has been shown by our laboratory
(Potter et al, 1998) and others (Franco et al, 2004), calpain-dependent remodeling of the actin-
associated cytoskeleton is needed for protrusion formation and cell spreading as well as
remodeling the focal contact-enriched membrane anchoring domains needed to disengage
rearward adhesions such that cellular translocation can be fostering (by transiently disengaging
focal adhesions via calpain-mediated talin proteolysis (Franco et al 2004). Results of our studies
not only support these earlier findings, but demonstrate that inhibition of calpain-dependent
cytoskeletal (talin) remodeling gives rise to enhanced stability of existing adhesion complexes,
a greater persistence of the actin-rich stress fibers and a locally elevated mechanical stiffness
linked to decreased talin and focal adhesion turnover. Further, we reason that there are likely
to be indirect effects of calpain inhibition on cytoskeletal effectors, which might include a
potential increase in RhoA activation through effects on the guanine exchange or activating
proteins (GEF/GAP), as has been suggested by others (Kulkarni, Goll and Fox 2002;
Mammoto, Huang and Ingber 2007; Miyazaki, Honda and Ohata 2009). Such increased RhoA
activation would induce higher contractile force production outside of the calpain-regulated
cytoskeletal effector pathways involved in regulating cell shape and motility since CALPST
treatment of living pericytes has no effect on RhoA-regulated cytoskeletal remodeling (Fig.
3). On the other hand, there is one report suggesting opposing effects of calpain on RhoA-
dependent cytoskeletal remodeling (Gonscherowski et al 2006), which may be cell- or
contractile protein isoform-specific since RhoA- and calpain-dependent mechanisms, which
control contractility and/or force transduction in non-muscle or smooth muscle-like cells may
not be identical (Herman and D’Amore, 1985; Kolyada et al 2003; Kutcher and Herman
2007; 2009; Durham and Herman 2009).
Given the dynamic nature pericyte-driven deformation of elastic substrata, the observations
that CALPST treatment of living cells yields differential effects on cytoskeletal-dependent
contractile events, i.e. decreased CCI and increased Eeff, suggests that calpain regulates a
dynamic interplay involved in generating or sustaining those cellular forces needed for
isotonically- and/or isometrically-contracting cytoplasmic domains. For example, we seldom
observe deformed substrata underlying regions of advancing cytoplasm actively engaged in
isotonically-contracting F-actin rich cytoplasmic domains (distal reaches of pseudopods,
filapods and membrane ruffles). This is in stark contradistinction to the actively deformed
zones of elastic substrata beneath domains that we posit to be engaged in isometric contraction
where force transduction is occurring in the absence of stress fiber length or cell shape changes.
We reason that such a calpain-controlled balance in pericyte contractility likely depends on
the dynamics of FA assembly/turnover, which has been shown to calpain- and talin-dependent
(Franco et al 2004). Moreover, our results also suggest a controlling role for calpain in a positive
feedback loop existing between force transduction and FA stabilization (Balaban et al 2001;
Bershadsky et al 2006; Burridge and Chrzanowska-Wodnicka 1996). Indeed, this dynamically
reciprocal signaling loop could likely be controlled by calpain, which cleaves talin and fosters
β integrin subunit dissociation from other FA- and cytoskeletal-associating proteins (Franco
and Huttenlocher 2005). However, such control could be lost with calpain inhibition, resulting
in (i) non-cleaved talin, (ii) inhibition of FA turnover and (iii) enhanced local stiffening. This
hypothesis is consistent with our observations of decreased CCI and increased Eeff above or
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“on” substrata wrinkles in response to calpain inhibitor CALPST. In addition, the observation
of increased stiffness (Eeff “on” wrinkles) is consistent with the reported enlargement of
paxillin-and vinculin-containing FAs caused by talin L432G expressed in talin1 null cells
(Franco et al 2004), which could likely lead to FA stabilization, increased association of
filamentous actin, and thus be coupled with increased magnitude of contractile force. Our
combined data suggest a preliminary model wherein increases in Rho GTP-dependent
cytoskeletal contractile events anchored at the FA are countered via calpain-dependent
modulation of cellular mechanotransduction. Thus, by selectively targeting key FA-associated
cytoskeletal substrates, such as talin, pericytes’ control of contractile forces against adherent
substrata (extracellular matrix and basement membrane) or adjacent microvascular endothelial
cells (cell-cell association) could be regulated. More detailed studies of the kinetics and
distribution of contractile forces, as well as of calpain-dependent signaling pathways and
mechanisms involved in generation of these forces, are needed to further elucidate and validate
such a regulatory model.
Calpain control of cellular contractility and human pathogenesis
In addition to identifying calpain and talin functional interactions as an important regulatory
mechanism of cell contractility in general, our results offer insights into phenomena that
underlie microvascular disorders such as in retinopathies. The calpain pathway has been
implicated in as a mechanism of apoptotic retinal cell death produced by elevated intraocular
pressure and hypoxia leading to retinal degenerations associated with glaucoma and retinitis
pigmentosa (Paquet-Durand, Johnson and Ekstrom 2007; Azuma and Shearer 2008).
Moreover, deregulated contractility of pericytes has been postulated as a potential,
chemomechanically transduced cause of microvascular endothelial hyperproliferation and
perturbed tone in pathogenesis of diabetic and age related retinopathies (Kutcher and Herman
2009; Kutcher et al 2007). Additionally, deregulated contractile force transduction seems an
even more relevant target of investigation and potential therapeutic interventions, as we have
most recently demonstrated that the strains exerted by pericytes onto substrata can be sufficient
to alter the effective elastic moduli of basement membrane; this substrata stiffening would
provide indirect modulation of the EC mechanical microenvironment, in addition to the direct
mechanical strain pericytes can exert via contraction (Lee et al 2010). Further investigation
into the effects of FA manipulations on pericyte-dependent EC growth control would validate
this hypothesis of such a mechanism contributing to microvascular disorders.
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Fig. 1. Molecular control of pericyte contractility
Bovine retinal pericytes were electroporated either with plasmids encoding control EGFP and
fusion of EGFP-talin, EGFP-talin L432G (calpain-resistant mutant) or EGFP-vinculin, or co-
transfected (in 1:4 ratio) with plasmids encoding EGFP and RhoA Q63L (dominant active
mutant). On next day, transfected pericytes were seeded onto deformable silicone substrata.
After 24 h live GFP-positive cells were evaluated by microscopy. (A) A pericyte
overexpressing EGFP-talin is shown wrinkling silicone substratum (left panel - phase contrast
image, central panel – fluorescence image, right panel – overlay image of phase contrast and
fluorescence pseudocolored red and green, respectively). An arrow points at cell contraction-
driven deformations of the substrata. (B) A graph showing contractile force transduction, as
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measured by cell contractility index (CCI) and described in Methods, in pericytes
overexpressing designated proteins, CCI for EGFP control was equaled to 1, to which other
CCI values were normalized. Asterisk (*) indicates statistically significant difference between
control EGFP and EGFP-talin (p<4E-9), and EGFP/RhoA Q63L (p<0.04), respectively.
Double asterisk (**) indicates statistically significant difference between EGFP-talin and
EGFP-talin L432G (p<2E-05). The CCI of EGFP-talin L432G and EGFP-vinculin were not
statistically significantly different from control EGFP. Scale bar = 30 µm.
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Fig. 2. Calpain regulates pericyte contractile force production
Untransfected pericyte force production, as measured by Cell Contractility Index (CCI, see
Materials and Methods) was monitored and quantified as a function of calpain inhibition.
CALPST and its inactive mutant CALPSTala were added at final concentrations of 0, 5, 25,
100 µM for 24, 48 and 96 hours of treatment. The inhibitors were added at the time of seeding
pericytes onto deformable substrata and re-applied in a fresh medium at 24 hr in cultures scored
at 48 h, and at 24 and 72 hr in cultures scored at 96 h. Asterisk (*) indicates statistically
significant differences between pericytes treated with 100 µM CALPST for 48 h and either
untreated (p<4E-04), treated with 100 µM CALPSTala for 48 h (p<0.01) or 25 µM CALPST
for 48 h (p<0.01). Double asterisk (**) indicates statistically significant differences between
pericytes treated with 100 µM CALPST for 96 h and either untreated (p<2E-07), treated with
100 µM CALPSTala for 96 h (p<6E-05), 100 µM CALPSTala for 96 h (p<5E-04) or 25 µM
CALPST for 96 h (p<5E-04),
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Fig. 3. Talin, but not RhoA-induced pericyte contractility is calpain-dependent
Bovine retinal pericytes were electroporated either with plasmids encoding control EGFP and
fusion of EGFP-talin, EGFP-talin L432G (calpain-resistant mutant, or co-transfected (in 1:4
ratio) with plasmids encoding EGFP and RhoA Q63L (dominant active mutant). On next day,
transfected pericytes were seeded onto deformable silicone substrata. After 24 h live GFP-
positive cells were evaluated by microscopy. On next day, transfected pericytes were seeded
onto deformable silicone substrata, and either left untreated or treated with calpain inhibitor
CALPST at 25 µM final concentration for 24 h. Contractility of samples was analyzed for Cell
Contractility Index (CCI) and normalized to untreated EGFP control equaled to 1. Asterisk (*)
indicates statistically significant difference between CALPST treated EGFP-talin and
untreated EGFP-talin (p<2E-6). CALPST treatment of other cultures does not cause
statistically significant differences, as compared with their corresponding untreated controls.
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Fig. 4. Assessment of local cell stiffness via atomic force microscope (AFM)-enabled
nanoindentation
Left (A) and right (C) images show optical microscopy images of the cantilever positioned
directly above and far from wrinkled regions of the silicone substrata, respectively (on-wrinkle
and off-wrinkle, respectively). Black arrowheads indicate wrinkles observable in silicone
substrate. Central diagram (B) demonstrates the experimental set-up, wherein pericytes were
grown on deformable silicone substrata and exhibited actin stress fibers (also marked by the
star in left inset); pericyte contractile forces deformed or wrinkled the substratum, and
indentation of subcellular regions was conducted near and far from regions of visible substrata
contraction. Insets in (A) – (C) show AFM deflection images of pericytes and underlying
silocone substrata with cell-generated wrinkle deformations. (D) Subcellular stiffness
expressed as indentation effective elastic moduli Eeff at on- and off-wrinkle positions, as a
function of exposure to calpain inhibitor CALPST (100 µM final concentration, 24 h). At least
five cells were analyzed per condition, and data are normalized by the value of Eeff for the
untreated cells on-wrinkle stiffness. Asterisk (*) indicates statistically significant difference in
Eeff between on-wrinkle and off-wrinkle locations (p<0.05); and plus sign (‡) indicates
statistically significant differences in Eeff for CALPST-treated as compared to untreated or
CALPST-ala cells (p<0.001); double asterisk (**) indicates statistically significant difference
in Eeff between CALPST treated on-wrinkle and off-wrinkle (p<0.001). Scale bar = 20 µm.
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